The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA Peptide Update: Category 2 Removals Explained